The epidermal growth factor receptor (EGFR, also known as HER1) is augmented in some solid tumors and its altered expression or mutation has been described as a tumor growth enhancer in different types of cancer, including ovarian cancer, glioblastoma and hepatocellular carcinoma (HCC) [73,74,75,76,77]. Here, EGFR is linked to ovarian cancer.